Medical Care
Global Liposomal Drug Delivery System Market Research Report 2025
- May 12, 25
- ID: 236259
- Pages: 84
- Figures: 82
- Views: 9
The global market for Liposomal Drug Delivery System was valued at US$ 4361 million in the year 2024 and is projected to reach a revised size of US$ 9077 million by 2031, growing at a CAGR of 11.2% during the forecast period.
A liposomal drug delivery system refers to a method of delivering therapeutic agents, such as drugs or genetic material, using liposomes. Liposomes are microscopic vesicles composed of lipid bilayers, mimicking the structure of cell membranes. These vesicles can encapsulate drugs, protecting them from degradation and improving their delivery to specific target tissues or cells in the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug Delivery System.
The Liposomal Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services, Inc. (U.S.)
Gilead Sciences Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd (Israel)
Janssen Pharmaceuticals Inc. (Belgium)
CELSION corporation (U.S.）
Abbott (U.S.)
Ipsen Pharma (France)
Spectrum Pharmaceuticals, Inc. (U.S.)
Takeda Pharmaceutical Company Limited. (Japan)
Segment by Type
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A liposomal drug delivery system refers to a method of delivering therapeutic agents, such as drugs or genetic material, using liposomes. Liposomes are microscopic vesicles composed of lipid bilayers, mimicking the structure of cell membranes. These vesicles can encapsulate drugs, protecting them from degradation and improving their delivery to specific target tissues or cells in the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug Delivery System.
The Liposomal Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services, Inc. (U.S.)
Gilead Sciences Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd (Israel)
Janssen Pharmaceuticals Inc. (Belgium)
CELSION corporation (U.S.）
Abbott (U.S.)
Ipsen Pharma (France)
Spectrum Pharmaceuticals, Inc. (U.S.)
Takeda Pharmaceutical Company Limited. (Japan)
Segment by Type
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Paclitaxel
1.2.4 Liposomal Amphotericin B
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomal Drug Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Drug Delivery System Market Perspective (2020-2031)
2.2 Global Liposomal Drug Delivery System Growth Trends by Region
2.2.1 Global Liposomal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomal Drug Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Liposomal Drug Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Liposomal Drug Delivery System Market Dynamics
2.3.1 Liposomal Drug Delivery System Industry Trends
2.3.2 Liposomal Drug Delivery System Market Drivers
2.3.3 Liposomal Drug Delivery System Market Challenges
2.3.4 Liposomal Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Drug Delivery System Players by Revenue
3.1.1 Global Top Liposomal Drug Delivery System Players by Revenue (2020-2025)
3.1.2 Global Liposomal Drug Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Liposomal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomal Drug Delivery System Revenue
3.4 Global Liposomal Drug Delivery System Market Concentration Ratio
3.4.1 Global Liposomal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug Delivery System Revenue in 2024
3.5 Global Key Players of Liposomal Drug Delivery System Head office and Area Served
3.6 Global Key Players of Liposomal Drug Delivery System, Product and Application
3.7 Global Key Players of Liposomal Drug Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Drug Delivery System Breakdown Data by Type
4.1 Global Liposomal Drug Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Liposomal Drug Delivery System Forecasted Market Size by Type (2026-2031)
5 Liposomal Drug Delivery System Breakdown Data by Application
5.1 Global Liposomal Drug Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Liposomal Drug Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomal Drug Delivery System Market Size (2020-2031)
6.2 North America Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomal Drug Delivery System Market Size by Country (2020-2025)
6.4 North America Liposomal Drug Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Drug Delivery System Market Size (2020-2031)
7.2 Europe Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomal Drug Delivery System Market Size by Country (2020-2025)
7.4 Europe Liposomal Drug Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Drug Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Liposomal Drug Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal Drug Delivery System Market Size (2020-2031)
9.2 Latin America Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomal Drug Delivery System Market Size by Country (2020-2025)
9.4 Latin America Liposomal Drug Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Drug Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services, Inc. (U.S.)
11.1.1 Johnson & Johnson Services, Inc. (U.S.) Company Details
11.1.2 Johnson & Johnson Services, Inc. (U.S.) Business Overview
11.1.3 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.1.4 Johnson & Johnson Services, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.1.5 Johnson & Johnson Services, Inc. (U.S.) Recent Development
11.2 Gilead Sciences Inc. (U.S.)
11.2.1 Gilead Sciences Inc. (U.S.) Company Details
11.2.2 Gilead Sciences Inc. (U.S.) Business Overview
11.2.3 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.2.4 Gilead Sciences Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.2.5 Gilead Sciences Inc. (U.S.) Recent Development
11.3 Sun Pharmaceutical Industries Ltd. (India)
11.3.1 Sun Pharmaceutical Industries Ltd. (India) Company Details
11.3.2 Sun Pharmaceutical Industries Ltd. (India) Business Overview
11.3.3 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Introduction
11.3.4 Sun Pharmaceutical Industries Ltd. (India) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.3.5 Sun Pharmaceutical Industries Ltd. (India) Recent Development
11.4 Novartis AG (Switzerland)
11.4.1 Novartis AG (Switzerland) Company Details
11.4.2 Novartis AG (Switzerland) Business Overview
11.4.3 Novartis AG (Switzerland) Liposomal Drug Delivery System Introduction
11.4.4 Novartis AG (Switzerland) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.4.5 Novartis AG (Switzerland) Recent Development
11.5 Teva Pharmaceutical Industries Ltd (Israel)
11.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details
11.5.2 Teva Pharmaceutical Industries Ltd (Israel) Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Introduction
11.5.4 Teva Pharmaceutical Industries Ltd (Israel) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Development
11.6 Janssen Pharmaceuticals Inc. (Belgium)
11.6.1 Janssen Pharmaceuticals Inc. (Belgium) Company Details
11.6.2 Janssen Pharmaceuticals Inc. (Belgium) Business Overview
11.6.3 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Introduction
11.6.4 Janssen Pharmaceuticals Inc. (Belgium) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.6.5 Janssen Pharmaceuticals Inc. (Belgium) Recent Development
11.7 CELSION corporation (U.S.）
11.7.1 CELSION corporation (U.S.） Company Details
11.7.2 CELSION corporation (U.S.） Business Overview
11.7.3 CELSION corporation (U.S.） Liposomal Drug Delivery System Introduction
11.7.4 CELSION corporation (U.S.） Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.7.5 CELSION corporation (U.S.） Recent Development
11.8 Abbott (U.S.)
11.8.1 Abbott (U.S.) Company Details
11.8.2 Abbott (U.S.) Business Overview
11.8.3 Abbott (U.S.) Liposomal Drug Delivery System Introduction
11.8.4 Abbott (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.8.5 Abbott (U.S.) Recent Development
11.9 Ipsen Pharma (France)
11.9.1 Ipsen Pharma (France) Company Details
11.9.2 Ipsen Pharma (France) Business Overview
11.9.3 Ipsen Pharma (France) Liposomal Drug Delivery System Introduction
11.9.4 Ipsen Pharma (France) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.9.5 Ipsen Pharma (France) Recent Development
11.10 Spectrum Pharmaceuticals, Inc. (U.S.)
11.10.1 Spectrum Pharmaceuticals, Inc. (U.S.) Company Details
11.10.2 Spectrum Pharmaceuticals, Inc. (U.S.) Business Overview
11.10.3 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.10.4 Spectrum Pharmaceuticals, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.10.5 Spectrum Pharmaceuticals, Inc. (U.S.) Recent Development
11.11 Takeda Pharmaceutical Company Limited. (Japan)
11.11.1 Takeda Pharmaceutical Company Limited. (Japan) Company Details
11.11.2 Takeda Pharmaceutical Company Limited. (Japan) Business Overview
11.11.3 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Introduction
11.11.4 Takeda Pharmaceutical Company Limited. (Japan) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.11.5 Takeda Pharmaceutical Company Limited. (Japan) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Paclitaxel
1.2.4 Liposomal Amphotericin B
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomal Drug Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Drug Delivery System Market Perspective (2020-2031)
2.2 Global Liposomal Drug Delivery System Growth Trends by Region
2.2.1 Global Liposomal Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liposomal Drug Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Liposomal Drug Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Liposomal Drug Delivery System Market Dynamics
2.3.1 Liposomal Drug Delivery System Industry Trends
2.3.2 Liposomal Drug Delivery System Market Drivers
2.3.3 Liposomal Drug Delivery System Market Challenges
2.3.4 Liposomal Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Drug Delivery System Players by Revenue
3.1.1 Global Top Liposomal Drug Delivery System Players by Revenue (2020-2025)
3.1.2 Global Liposomal Drug Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Liposomal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liposomal Drug Delivery System Revenue
3.4 Global Liposomal Drug Delivery System Market Concentration Ratio
3.4.1 Global Liposomal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug Delivery System Revenue in 2024
3.5 Global Key Players of Liposomal Drug Delivery System Head office and Area Served
3.6 Global Key Players of Liposomal Drug Delivery System, Product and Application
3.7 Global Key Players of Liposomal Drug Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Drug Delivery System Breakdown Data by Type
4.1 Global Liposomal Drug Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Liposomal Drug Delivery System Forecasted Market Size by Type (2026-2031)
5 Liposomal Drug Delivery System Breakdown Data by Application
5.1 Global Liposomal Drug Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Liposomal Drug Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liposomal Drug Delivery System Market Size (2020-2031)
6.2 North America Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liposomal Drug Delivery System Market Size by Country (2020-2025)
6.4 North America Liposomal Drug Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Drug Delivery System Market Size (2020-2031)
7.2 Europe Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liposomal Drug Delivery System Market Size by Country (2020-2025)
7.4 Europe Liposomal Drug Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Drug Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Liposomal Drug Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal Drug Delivery System Market Size (2020-2031)
9.2 Latin America Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liposomal Drug Delivery System Market Size by Country (2020-2025)
9.4 Latin America Liposomal Drug Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Drug Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Liposomal Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services, Inc. (U.S.)
11.1.1 Johnson & Johnson Services, Inc. (U.S.) Company Details
11.1.2 Johnson & Johnson Services, Inc. (U.S.) Business Overview
11.1.3 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.1.4 Johnson & Johnson Services, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.1.5 Johnson & Johnson Services, Inc. (U.S.) Recent Development
11.2 Gilead Sciences Inc. (U.S.)
11.2.1 Gilead Sciences Inc. (U.S.) Company Details
11.2.2 Gilead Sciences Inc. (U.S.) Business Overview
11.2.3 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.2.4 Gilead Sciences Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.2.5 Gilead Sciences Inc. (U.S.) Recent Development
11.3 Sun Pharmaceutical Industries Ltd. (India)
11.3.1 Sun Pharmaceutical Industries Ltd. (India) Company Details
11.3.2 Sun Pharmaceutical Industries Ltd. (India) Business Overview
11.3.3 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Introduction
11.3.4 Sun Pharmaceutical Industries Ltd. (India) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.3.5 Sun Pharmaceutical Industries Ltd. (India) Recent Development
11.4 Novartis AG (Switzerland)
11.4.1 Novartis AG (Switzerland) Company Details
11.4.2 Novartis AG (Switzerland) Business Overview
11.4.3 Novartis AG (Switzerland) Liposomal Drug Delivery System Introduction
11.4.4 Novartis AG (Switzerland) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.4.5 Novartis AG (Switzerland) Recent Development
11.5 Teva Pharmaceutical Industries Ltd (Israel)
11.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details
11.5.2 Teva Pharmaceutical Industries Ltd (Israel) Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Introduction
11.5.4 Teva Pharmaceutical Industries Ltd (Israel) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.5.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Development
11.6 Janssen Pharmaceuticals Inc. (Belgium)
11.6.1 Janssen Pharmaceuticals Inc. (Belgium) Company Details
11.6.2 Janssen Pharmaceuticals Inc. (Belgium) Business Overview
11.6.3 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Introduction
11.6.4 Janssen Pharmaceuticals Inc. (Belgium) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.6.5 Janssen Pharmaceuticals Inc. (Belgium) Recent Development
11.7 CELSION corporation (U.S.）
11.7.1 CELSION corporation (U.S.） Company Details
11.7.2 CELSION corporation (U.S.） Business Overview
11.7.3 CELSION corporation (U.S.） Liposomal Drug Delivery System Introduction
11.7.4 CELSION corporation (U.S.） Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.7.5 CELSION corporation (U.S.） Recent Development
11.8 Abbott (U.S.)
11.8.1 Abbott (U.S.) Company Details
11.8.2 Abbott (U.S.) Business Overview
11.8.3 Abbott (U.S.) Liposomal Drug Delivery System Introduction
11.8.4 Abbott (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.8.5 Abbott (U.S.) Recent Development
11.9 Ipsen Pharma (France)
11.9.1 Ipsen Pharma (France) Company Details
11.9.2 Ipsen Pharma (France) Business Overview
11.9.3 Ipsen Pharma (France) Liposomal Drug Delivery System Introduction
11.9.4 Ipsen Pharma (France) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.9.5 Ipsen Pharma (France) Recent Development
11.10 Spectrum Pharmaceuticals, Inc. (U.S.)
11.10.1 Spectrum Pharmaceuticals, Inc. (U.S.) Company Details
11.10.2 Spectrum Pharmaceuticals, Inc. (U.S.) Business Overview
11.10.3 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Introduction
11.10.4 Spectrum Pharmaceuticals, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.10.5 Spectrum Pharmaceuticals, Inc. (U.S.) Recent Development
11.11 Takeda Pharmaceutical Company Limited. (Japan)
11.11.1 Takeda Pharmaceutical Company Limited. (Japan) Company Details
11.11.2 Takeda Pharmaceutical Company Limited. (Japan) Business Overview
11.11.3 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Introduction
11.11.4 Takeda Pharmaceutical Company Limited. (Japan) Revenue in Liposomal Drug Delivery System Business (2020-2025)
11.11.5 Takeda Pharmaceutical Company Limited. (Japan) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Liposomal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Paclitaxel
Table 4. Key Players of Liposomal Amphotericin B
Table 5. Key Players of Others
Table 6. Global Liposomal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposomal Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liposomal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liposomal Drug Delivery System Market Share by Region (2020-2025)
Table 10. Global Liposomal Drug Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liposomal Drug Delivery System Market Share by Region (2026-2031)
Table 12. Liposomal Drug Delivery System Market Trends
Table 13. Liposomal Drug Delivery System Market Drivers
Table 14. Liposomal Drug Delivery System Market Challenges
Table 15. Liposomal Drug Delivery System Market Restraints
Table 16. Global Liposomal Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liposomal Drug Delivery System Market Share by Players (2020-2025)
Table 18. Global Top Liposomal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery System as of 2024)
Table 19. Ranking of Global Top Liposomal Drug Delivery System Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liposomal Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liposomal Drug Delivery System, Headquarters and Area Served
Table 22. Global Key Players of Liposomal Drug Delivery System, Product and Application
Table 23. Global Key Players of Liposomal Drug Delivery System, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposomal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liposomal Drug Delivery System Revenue Market Share by Type (2020-2025)
Table 27. Global Liposomal Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liposomal Drug Delivery System Revenue Market Share by Type (2026-2031)
Table 29. Global Liposomal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liposomal Drug Delivery System Revenue Market Share by Application (2020-2025)
Table 31. Global Liposomal Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liposomal Drug Delivery System Revenue Market Share by Application (2026-2031)
Table 33. North America Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liposomal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 48. Johnson & Johnson Services, Inc. (U.S.) Company Details
Table 49. Johnson & Johnson Services, Inc. (U.S.) Business Overview
Table 50. Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Product
Table 51. Johnson & Johnson Services, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 52. Johnson & Johnson Services, Inc. (U.S.) Recent Development
Table 53. Gilead Sciences Inc. (U.S.) Company Details
Table 54. Gilead Sciences Inc. (U.S.) Business Overview
Table 55. Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Product
Table 56. Gilead Sciences Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 57. Gilead Sciences Inc. (U.S.) Recent Development
Table 58. Sun Pharmaceutical Industries Ltd. (India) Company Details
Table 59. Sun Pharmaceutical Industries Ltd. (India) Business Overview
Table 60. Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Product
Table 61. Sun Pharmaceutical Industries Ltd. (India) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 62. Sun Pharmaceutical Industries Ltd. (India) Recent Development
Table 63. Novartis AG (Switzerland) Company Details
Table 64. Novartis AG (Switzerland) Business Overview
Table 65. Novartis AG (Switzerland) Liposomal Drug Delivery System Product
Table 66. Novartis AG (Switzerland) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 67. Novartis AG (Switzerland) Recent Development
Table 68. Teva Pharmaceutical Industries Ltd (Israel) Company Details
Table 69. Teva Pharmaceutical Industries Ltd (Israel) Business Overview
Table 70. Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Product
Table 71. Teva Pharmaceutical Industries Ltd (Israel) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 72. Teva Pharmaceutical Industries Ltd (Israel) Recent Development
Table 73. Janssen Pharmaceuticals Inc. (Belgium) Company Details
Table 74. Janssen Pharmaceuticals Inc. (Belgium) Business Overview
Table 75. Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Product
Table 76. Janssen Pharmaceuticals Inc. (Belgium) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 77. Janssen Pharmaceuticals Inc. (Belgium) Recent Development
Table 78. CELSION corporation (U.S.） Company Details
Table 79. CELSION corporation (U.S.） Business Overview
Table 80. CELSION corporation (U.S.） Liposomal Drug Delivery System Product
Table 81. CELSION corporation (U.S.） Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 82. CELSION corporation (U.S.） Recent Development
Table 83. Abbott (U.S.) Company Details
Table 84. Abbott (U.S.) Business Overview
Table 85. Abbott (U.S.) Liposomal Drug Delivery System Product
Table 86. Abbott (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 87. Abbott (U.S.) Recent Development
Table 88. Ipsen Pharma (France) Company Details
Table 89. Ipsen Pharma (France) Business Overview
Table 90. Ipsen Pharma (France) Liposomal Drug Delivery System Product
Table 91. Ipsen Pharma (France) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 92. Ipsen Pharma (France) Recent Development
Table 93. Spectrum Pharmaceuticals, Inc. (U.S.) Company Details
Table 94. Spectrum Pharmaceuticals, Inc. (U.S.) Business Overview
Table 95. Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Product
Table 96. Spectrum Pharmaceuticals, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 97. Spectrum Pharmaceuticals, Inc. (U.S.) Recent Development
Table 98. Takeda Pharmaceutical Company Limited. (Japan) Company Details
Table 99. Takeda Pharmaceutical Company Limited. (Japan) Business Overview
Table 100. Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Product
Table 101. Takeda Pharmaceutical Company Limited. (Japan) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 102. Takeda Pharmaceutical Company Limited. (Japan) Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Liposomal Drug Delivery System Picture
Figure 2. Global Liposomal Drug Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomal Drug Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Liposomal Doxorubicin Features
Figure 5. Liposomal Paclitaxel Features
Figure 6. Liposomal Amphotericin B Features
Figure 7. Others Features
Figure 8. Global Liposomal Drug Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposomal Drug Delivery System Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Specialty Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Liposomal Drug Delivery System Report Years Considered
Figure 14. Global Liposomal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Liposomal Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Liposomal Drug Delivery System Market Share by Region: 2024 VS 2031
Figure 17. Global Liposomal Drug Delivery System Market Share by Players in 2024
Figure 18. Global Top Liposomal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Liposomal Drug Delivery System Revenue in 2024
Figure 20. North America Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 22. United States Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 26. Germany Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposomal Drug Delivery System Market Share by Region (2020-2031)
Figure 34. China Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 42. Mexico Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 46. Turkey Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Johnson & Johnson Services, Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 50. Gilead Sciences Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 51. Sun Pharmaceutical Industries Ltd. (India) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 52. Novartis AG (Switzerland) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 53. Teva Pharmaceutical Industries Ltd (Israel) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 54. Janssen Pharmaceuticals Inc. (Belgium) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 55. CELSION corporation (U.S.） Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 56. Abbott (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 57. Ipsen Pharma (France) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 58. Spectrum Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 59. Takeda Pharmaceutical Company Limited. (Japan) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Liposomal Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Paclitaxel
Table 4. Key Players of Liposomal Amphotericin B
Table 5. Key Players of Others
Table 6. Global Liposomal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Liposomal Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Liposomal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Liposomal Drug Delivery System Market Share by Region (2020-2025)
Table 10. Global Liposomal Drug Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Liposomal Drug Delivery System Market Share by Region (2026-2031)
Table 12. Liposomal Drug Delivery System Market Trends
Table 13. Liposomal Drug Delivery System Market Drivers
Table 14. Liposomal Drug Delivery System Market Challenges
Table 15. Liposomal Drug Delivery System Market Restraints
Table 16. Global Liposomal Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Liposomal Drug Delivery System Market Share by Players (2020-2025)
Table 18. Global Top Liposomal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery System as of 2024)
Table 19. Ranking of Global Top Liposomal Drug Delivery System Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Liposomal Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Liposomal Drug Delivery System, Headquarters and Area Served
Table 22. Global Key Players of Liposomal Drug Delivery System, Product and Application
Table 23. Global Key Players of Liposomal Drug Delivery System, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposomal Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Liposomal Drug Delivery System Revenue Market Share by Type (2020-2025)
Table 27. Global Liposomal Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Liposomal Drug Delivery System Revenue Market Share by Type (2026-2031)
Table 29. Global Liposomal Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Liposomal Drug Delivery System Revenue Market Share by Application (2020-2025)
Table 31. Global Liposomal Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Liposomal Drug Delivery System Revenue Market Share by Application (2026-2031)
Table 33. North America Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Liposomal Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Liposomal Drug Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Liposomal Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Liposomal Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 48. Johnson & Johnson Services, Inc. (U.S.) Company Details
Table 49. Johnson & Johnson Services, Inc. (U.S.) Business Overview
Table 50. Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Product
Table 51. Johnson & Johnson Services, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 52. Johnson & Johnson Services, Inc. (U.S.) Recent Development
Table 53. Gilead Sciences Inc. (U.S.) Company Details
Table 54. Gilead Sciences Inc. (U.S.) Business Overview
Table 55. Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Product
Table 56. Gilead Sciences Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 57. Gilead Sciences Inc. (U.S.) Recent Development
Table 58. Sun Pharmaceutical Industries Ltd. (India) Company Details
Table 59. Sun Pharmaceutical Industries Ltd. (India) Business Overview
Table 60. Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Product
Table 61. Sun Pharmaceutical Industries Ltd. (India) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 62. Sun Pharmaceutical Industries Ltd. (India) Recent Development
Table 63. Novartis AG (Switzerland) Company Details
Table 64. Novartis AG (Switzerland) Business Overview
Table 65. Novartis AG (Switzerland) Liposomal Drug Delivery System Product
Table 66. Novartis AG (Switzerland) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 67. Novartis AG (Switzerland) Recent Development
Table 68. Teva Pharmaceutical Industries Ltd (Israel) Company Details
Table 69. Teva Pharmaceutical Industries Ltd (Israel) Business Overview
Table 70. Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Product
Table 71. Teva Pharmaceutical Industries Ltd (Israel) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 72. Teva Pharmaceutical Industries Ltd (Israel) Recent Development
Table 73. Janssen Pharmaceuticals Inc. (Belgium) Company Details
Table 74. Janssen Pharmaceuticals Inc. (Belgium) Business Overview
Table 75. Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Product
Table 76. Janssen Pharmaceuticals Inc. (Belgium) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 77. Janssen Pharmaceuticals Inc. (Belgium) Recent Development
Table 78. CELSION corporation (U.S.） Company Details
Table 79. CELSION corporation (U.S.） Business Overview
Table 80. CELSION corporation (U.S.） Liposomal Drug Delivery System Product
Table 81. CELSION corporation (U.S.） Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 82. CELSION corporation (U.S.） Recent Development
Table 83. Abbott (U.S.) Company Details
Table 84. Abbott (U.S.) Business Overview
Table 85. Abbott (U.S.) Liposomal Drug Delivery System Product
Table 86. Abbott (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 87. Abbott (U.S.) Recent Development
Table 88. Ipsen Pharma (France) Company Details
Table 89. Ipsen Pharma (France) Business Overview
Table 90. Ipsen Pharma (France) Liposomal Drug Delivery System Product
Table 91. Ipsen Pharma (France) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 92. Ipsen Pharma (France) Recent Development
Table 93. Spectrum Pharmaceuticals, Inc. (U.S.) Company Details
Table 94. Spectrum Pharmaceuticals, Inc. (U.S.) Business Overview
Table 95. Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Product
Table 96. Spectrum Pharmaceuticals, Inc. (U.S.) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 97. Spectrum Pharmaceuticals, Inc. (U.S.) Recent Development
Table 98. Takeda Pharmaceutical Company Limited. (Japan) Company Details
Table 99. Takeda Pharmaceutical Company Limited. (Japan) Business Overview
Table 100. Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Product
Table 101. Takeda Pharmaceutical Company Limited. (Japan) Revenue in Liposomal Drug Delivery System Business (2020-2025) & (US$ Million)
Table 102. Takeda Pharmaceutical Company Limited. (Japan) Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Liposomal Drug Delivery System Picture
Figure 2. Global Liposomal Drug Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomal Drug Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Liposomal Doxorubicin Features
Figure 5. Liposomal Paclitaxel Features
Figure 6. Liposomal Amphotericin B Features
Figure 7. Others Features
Figure 8. Global Liposomal Drug Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposomal Drug Delivery System Market Share by Application: 2024 VS 2031
Figure 10. Hospital Case Studies
Figure 11. Specialty Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Liposomal Drug Delivery System Report Years Considered
Figure 14. Global Liposomal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Liposomal Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Liposomal Drug Delivery System Market Share by Region: 2024 VS 2031
Figure 17. Global Liposomal Drug Delivery System Market Share by Players in 2024
Figure 18. Global Top Liposomal Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Liposomal Drug Delivery System Revenue in 2024
Figure 20. North America Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 22. United States Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 26. Germany Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Liposomal Drug Delivery System Market Share by Region (2020-2031)
Figure 34. China Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 42. Mexico Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Liposomal Drug Delivery System Market Share by Country (2020-2031)
Figure 46. Turkey Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Liposomal Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Johnson & Johnson Services, Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 50. Gilead Sciences Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 51. Sun Pharmaceutical Industries Ltd. (India) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 52. Novartis AG (Switzerland) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 53. Teva Pharmaceutical Industries Ltd (Israel) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 54. Janssen Pharmaceuticals Inc. (Belgium) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 55. CELSION corporation (U.S.） Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 56. Abbott (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 57. Ipsen Pharma (France) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 58. Spectrum Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 59. Takeda Pharmaceutical Company Limited. (Japan) Revenue Growth Rate in Liposomal Drug Delivery System Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232